DE69116224D1 - Behandlung von intraokularem Druck mit einer synergischen Kombination - Google Patents

Behandlung von intraokularem Druck mit einer synergischen Kombination

Info

Publication number
DE69116224D1
DE69116224D1 DE69116224T DE69116224T DE69116224D1 DE 69116224 D1 DE69116224 D1 DE 69116224D1 DE 69116224 T DE69116224 T DE 69116224T DE 69116224 T DE69116224 T DE 69116224T DE 69116224 D1 DE69116224 D1 DE 69116224D1
Authority
DE
Germany
Prior art keywords
treatment
synergistic combination
intraocular pressure
oculo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69116224T
Other languages
English (en)
Other versions
DE69116224T2 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DE69116224D1 publication Critical patent/DE69116224D1/de
Publication of DE69116224T2 publication Critical patent/DE69116224T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69116224T 1990-05-22 1991-05-21 Behandlung von intraokularem Druck mit einer synergischen Kombination Expired - Lifetime DE69116224T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13291090 1990-05-22

Publications (2)

Publication Number Publication Date
DE69116224D1 true DE69116224D1 (de) 1996-02-22
DE69116224T2 DE69116224T2 (de) 1996-05-23

Family

ID=15092386

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69116224T Expired - Lifetime DE69116224T2 (de) 1990-05-22 1991-05-21 Behandlung von intraokularem Druck mit einer synergischen Kombination

Country Status (10)

Country Link
US (1) US5166175A (de)
EP (1) EP0458590B1 (de)
JP (1) JP2511585B2 (de)
KR (1) KR960010435B1 (de)
AT (1) ATE132750T1 (de)
CA (1) CA2042937C (de)
DE (1) DE69116224T2 (de)
DK (1) DK0458590T3 (de)
ES (1) ES2084771T3 (de)
GR (1) GR3018651T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
EP0561073B1 (de) * 1992-03-19 2001-10-24 R-Tech Ueno Ltd. Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten
EP0668076B1 (de) * 1992-08-26 2002-09-04 Sucampo AG Stabilisierung von Prostansäurederivaten
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
CA2807081C (en) 2010-07-29 2018-09-18 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
DE68928551T2 (de) * 1988-10-01 1998-04-23 R Tech Ueno Ltd Oculare hypotensive Mittel

Also Published As

Publication number Publication date
US5166175A (en) 1992-11-24
DK0458590T3 (da) 1996-02-05
CA2042937A1 (en) 1991-11-23
ATE132750T1 (de) 1996-01-15
ES2084771T3 (es) 1996-05-16
CA2042937C (en) 2002-04-30
DE69116224T2 (de) 1996-05-23
KR960010435B1 (ko) 1996-08-01
JPH04253911A (ja) 1992-09-09
EP0458590B1 (de) 1996-01-10
EP0458590A1 (de) 1991-11-27
JP2511585B2 (ja) 1996-06-26
GR3018651T3 (en) 1996-04-30
KR910019621A (ko) 1991-12-19

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69116705T2 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
DE69116224T2 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
DE69105349D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
ATE133337T1 (de) Behandlung des glaukoms mit synergistischer kombination
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
DE69210286D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination
DE69123892T2 (de) Behandlung von Katarakt mit prostacyclinverbindungen
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition